Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
Identifieur interne : 001B77 ( Istex/Corpus ); précédent : 001B76; suivant : 001B78Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
Auteurs : E. J. Van Zuuren ; Z. FedorowiczSource :
- British Journal of Dermatology [ 0007-0963 ] ; 2013-02.
Url:
DOI: 10.1111/j.1365-2133.2012.11148.x
Links to Exploration step
ISTEX:5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><author><name sortKey="Van Zuuren, E J" sort="Van Zuuren, E J" uniqKey="Van Zuuren E" first="E. J." last="Van Zuuren">E. J. Van Zuuren</name><affiliation><mods:affiliation>Department of Dermatology, B1‐Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Fedorowicz, Z" sort="Fedorowicz, Z" uniqKey="Fedorowicz Z" first="Z." last="Fedorowicz">Z. Fedorowicz</name><affiliation><mods:affiliation>U.K. Cochrane Centre (Bahrain Branch), College of Medicine, AMA International University of Bahrain, Awali, Bahrain E‐mail: e.j.van_zuuren@lumc.nl</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1111/j.1365-2133.2012.11148.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">001B77</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001B77</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><author><name sortKey="Van Zuuren, E J" sort="Van Zuuren, E J" uniqKey="Van Zuuren E" first="E. J." last="Van Zuuren">E. J. Van Zuuren</name><affiliation><mods:affiliation>Department of Dermatology, B1‐Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</mods:affiliation></affiliation></author><author><name sortKey="Fedorowicz, Z" sort="Fedorowicz, Z" uniqKey="Fedorowicz Z" first="Z." last="Fedorowicz">Z. Fedorowicz</name><affiliation><mods:affiliation>U.K. Cochrane Centre (Bahrain Branch), College of Medicine, AMA International University of Bahrain, Awali, Bahrain E‐mail: e.j.van_zuuren@lumc.nl</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">British Journal of Dermatology</title><title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title><idno type="ISSN">0007-0963</idno><idno type="eISSN">1365-2133</idno><imprint><biblScope unit="vol">168</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="442">442</biblScope><biblScope unit="page" to="444">444</biblScope><biblScope unit="page-count">3</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-02">2013-02</date></imprint><idno type="ISSN">0007-0963</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0007-0963</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>rosacea</json:string><json:string>dermatol</json:string><json:string>cochrane</json:string><json:string>alopecia</json:string><json:string>fibrosing</json:string><json:string>randomized</json:string><json:string>ustekinumab</json:string><json:string>lichen</json:string><json:string>antituberculosis</json:string><json:string>frontal fibrosing alopecia</json:string><json:string>hrqol</json:string><json:string>psoriasis</json:string><json:string>reactivation</json:string><json:string>ltbi</json:string><json:string>british association</json:string><json:string>clinical trial</json:string><json:string>measurement property</json:string><json:string>ocular rosacea</json:string><json:string>patientreported outcome</json:string><json:string>rosacea international expert group</json:string><json:string>international consensus</json:string><json:string>ltbi reactivation</json:string><json:string>arch dermatol</json:string><json:string>systematic review</json:string><json:string>funding source</json:string><json:string>papulopustular rosacea</json:string><json:string>cochrane handbook</json:string></teeft></keywords><author><json:item><name>E.J. van Zuuren</name><affiliations><json:string>Department of Dermatology, B1‐Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</json:string></affiliations></json:item><json:item><name>Z. Fedorowicz</name><affiliations><json:string>U.K. Cochrane Centre (Bahrain Branch), College of Medicine, AMA International University of Bahrain, Awali, Bahrain E‐mail: e.j.van_zuuren@lumc.nl</json:string></affiliations></json:item></author><articleId><json:string>BJD11148</json:string></articleId><arkIstex>ark:/67375/WNG-JK3DLJX1-P</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>letter</json:string></originalGenre><qualityIndicators><score>3.8</score><pdfWordCount>1788</pdfWordCount><pdfCharCount>11717</pdfCharCount><pdfVersion>1.6</pdfVersion><pdfPageCount>3</pdfPageCount><pdfPageSize>595.276 x 782.362 pts</pdfPageSize><pdfWordsPerPage>596</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>1</abstractWordCount><abstractCharCount>0</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><pmid><json:string>22803770</json:string></pmid><genre><json:string>review-article</json:string></genre><host><title>British Journal of Dermatology</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2133</json:string></doi><issn><json:string>0007-0963</json:string></issn><eissn><json:string>1365-2133</json:string></eissn><publisherId><json:string>BJD</json:string></publisherId><volume>168</volume><issue>2</issue><pages><first>442</first><last>444</last><total>3</total></pages><genre><json:string>journal</json:string></genre><subject><json:item><value>Correspondence</value></json:item><json:item><value>Correspondence</value></json:item></subject></host><namedEntities><unitex><date><json:string>2013</json:string></date><geogName></geogName><orgName></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName></persName><placeName></placeName><ref_url></ref_url><ref_bibl></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-JK3DLJX1-P</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - dermatology</json:string></wos><scienceMetrix><json:string>1 - health sciences</json:string><json:string>2 - clinical medicine</json:string><json:string>3 - dermatology & venereal diseases</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Medicine</json:string><json:string>3 - Dermatology</json:string></scopus></categories><publicationDate>2013</publicationDate><copyrightDate>2013</copyrightDate><doi><json:string>10.1111/j.1365-2133.2012.11148.x</json:string></doi><id>5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><title level="a" type="short">Correspondence</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><licence>© 2012 The Authors. BJD © 2012 British Association of Dermatologists</licence></availability><date type="published" when="2013-02"></date></publicationStmt><notesStmt><note type="content-type" subtype="review-article" source="letter" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="review-article"><analytic><title level="a" type="main">Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><title level="a" type="short">Correspondence</title><author xml:id="author-0000"><persName><forename type="first">E.J.</forename><surname>van Zuuren</surname></persName><affiliation><orgName type="department">Department of Dermatology</orgName><address><addrLine>B1‐Q</addrLine><addrLine>Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</addrLine><country key="NL" xml:lang="en">THE NETHERLANDS</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">Z.</forename><surname>Fedorowicz</surname></persName><affiliation><orgName type="division">U.K. Cochrane Centre (Bahrain Branch)</orgName><orgName type="institution">College of Medicine</orgName><orgName type="institution">AMA International University of Bahrain</orgName><address><addrLine>Awali</addrLine><addrLine>Bahrain
E‐mail: e.j.van_zuuren@lumc.nl</addrLine><country key="BH" xml:lang="en">BAHRAIN</country></address></affiliation></author><idno type="istex">5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4</idno><idno type="ark">ark:/67375/WNG-JK3DLJX1-P</idno><idno type="DOI">10.1111/j.1365-2133.2012.11148.x</idno><idno type="unit">BJD11148</idno><idno type="toTypesetVersion">file:BJD.BJD11148.pdf</idno></analytic><monogr><title level="j" type="main">British Journal of Dermatology</title><title level="j" type="alt">BRITISH JOURNAL OF DERMATOLOGY</title><idno type="pISSN">0007-0963</idno><idno type="eISSN">1365-2133</idno><idno type="book-DOI">10.1111/(ISSN)1365-2133</idno><idno type="book-part-DOI">10.1111/bjd.2013.168.issue-2</idno><idno type="product">BJD</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">168</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="442">442</biblScope><biblScope unit="page" to="444">444</biblScope><biblScope unit="page-count">3</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2013-02"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><textClass><keywords rend="tocHeading1"><term>Correspondence</term></keywords><keywords rend="articleCategory"><term>Correspondence</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2133</doi><issn type="print">0007-0963</issn><issn type="electronic">1365-2133</issn><idGroup><id type="product" value="BJD"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="BRITISH JOURNAL OF DERMATOLOGY">British Journal of Dermatology</title></titleGroup></publicationMeta><publicationMeta level="part" position="02102"><doi origin="wiley">10.1111/bjd.2013.168.issue-2</doi><numberingGroup><numbering type="journalVolume" number="168">168</numbering><numbering type="journalIssue" number="2">2</numbering></numberingGroup><coverDate startDate="2013-02">February 2013</coverDate></publicationMeta><publicationMeta level="unit" type="letter" position="39" status="forIssue"><doi origin="wiley">10.1111/j.1365-2133.2012.11148.x</doi><idGroup><id type="unit" value="BJD11148"></id></idGroup><countGroup><count type="pageTotal" number="3"></count></countGroup><titleGroup><title type="tocHeading1">Correspondence</title><title type="articleCategory">Correspondence</title></titleGroup><copyright>© 2012 The Authors. BJD © 2012 British Association of Dermatologists</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:3.1.9 mode:FullText" date="2013-01-30"></event><event agent="SPS" date="2013-01-30" type="xmlCorrected"></event><event type="publishedOnlineAccepted" date="2012-07-14"></event><event type="publishedOnlineEarlyUnpaginated" date="2012-09-27"></event><event type="publishedOnlineFinalForm" date="2013-01-30"></event><event type="firstOnline" date="2012-09-27"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.6.4 mode:FullText" date="2015-10-02"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="442">442</numbering><numbering type="pageLast" number="444">444</numbering></numberingGroup><linkGroup><link type="toTypesetVersion" href="file:BJD.BJD11148.pdf"></link></linkGroup></publicationMeta><contentMeta><countGroup><count type="figureTotal" number="2"></count><count type="tableTotal" number="0"></count></countGroup><titleGroup><title type="main">Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title><title type="short">Correspondence</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>E.J.</givenNames><familyName>van Zuuren</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>Z.</givenNames><familyName>Fedorowicz</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="NL"><unparsedAffiliation>Department of Dermatology, B1‐Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="BH"><unparsedAffiliation>
U.K. Cochrane Centre (Bahrain Branch), College of Medicine, AMA International University of Bahrain, Awali, Bahrain
E‐mail: <email>e.j.van_zuuren@lumc.nl</email></unparsedAffiliation></affiliation></affiliationGroup></contentMeta><noteGroup><note xml:id="fn1"><p>Funding sources: none.</p></note><note xml:id="fn2"><p>Conflicts of interest: none declared.</p></note></noteGroup></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Correspondence</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea</title></titleInfo><name type="personal"><namePart type="given">E.J.</namePart><namePart type="family">van Zuuren</namePart><affiliation>Department of Dermatology, B1‐Q, Leiden University Medical Centre, PO Box 9600, 2300 RC Leiden, the Netherlands</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z.</namePart><namePart type="family">Fedorowicz</namePart><affiliation>U.K. Cochrane Centre (Bahrain Branch), College of Medicine, AMA International University of Bahrain, Awali, Bahrain E‐mail: e.j.van_zuuren@lumc.nl</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="review-article" displayLabel="letter" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-L5L7X3NF-P">review-article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2013-02</dateIssued><copyrightDate encoding="w3cdtf">2013</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">2</extent><extent unit="tables">0</extent></physicalDescription><relatedItem type="host"><titleInfo><title>British Journal of Dermatology</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><subject><genre>article-category</genre><topic>Correspondence</topic><topic>Correspondence</topic></subject><identifier type="ISSN">0007-0963</identifier><identifier type="eISSN">1365-2133</identifier><identifier type="DOI">10.1111/(ISSN)1365-2133</identifier><identifier type="PublisherID">BJD</identifier><part><date>2013</date><detail type="volume"><caption>vol.</caption><number>168</number></detail><detail type="issue"><caption>no.</caption><number>2</number></detail><extent unit="pages"><start>442</start><end>444</end><total>3</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Interventions for rosacea</title></titleInfo><name type="personal"><namePart type="given">EJ</namePart><namePart type="family">van Zuuren</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Kramer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Carter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">van Zuuren EJ, Kramer S, Carter B et al. Interventions for rosacea. Cochrane Database Syst Rev2011; 3:CD003262.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>CD003262</start></extent></part><relatedItem type="host"><titleInfo><title>Cochrane Database Syst Rev</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>3</number></detail><extent unit="pages"><start>CD003262</start></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>Cochrane Handbook for Systematic Reviews of Interventions 5.1.0</title></titleInfo><name type="personal"><namePart type="given">JPT</namePart><namePart type="family">Higgins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S</namePart><namePart type="family">Green</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>GRADE Handbook For Grading Quality of Evidence and Strength of Recommendation. Version 3.2</title></titleInfo><name type="corporate"><namePart>The GRADE Working Group</namePart></name><genre>other</genre></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Efficacy of topical cyclosporine for the treatment of ocular rosacea</title></titleInfo><name type="personal"><namePart type="given">BA</namePart><namePart type="family">Schechter</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">RS</namePart><namePart type="family">Katz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">LS</namePart><namePart type="family">Friedman</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Schechter BA, Katz RS, Friedman LS. Efficacy of topical cyclosporine for the treatment of ocular rosacea. Adv Ther2009; 26:651–9.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>651</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>Adv Ther</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>651</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle‐controlled double‐blind trial</title></titleInfo><name type="personal"><namePart type="given">S</namePart><namePart type="family">Weissenbacher</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J</namePart><namePart type="family">Merkl</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Hildebrandt</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Weissenbacher S, Merkl J, Hildebrandt B et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle‐controlled double‐blind trial. Br J Dermatol2007; 156:728–32.</note><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>728</start><end>32</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>156</number></detail><extent unit="pages"><start>728</start><end>32</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health‐related patient‐reported outcomes</title></titleInfo><name type="personal"><namePart type="given">LB</namePart><namePart type="family">Mokkink</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">CB</namePart><namePart type="family">Terwee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">DL</namePart><namePart type="family">Patrick</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mokkink LB, Terwee CB, Patrick DL et al. The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health‐related patient‐reported outcomes. J Clin Epidemiol2010; 63:737–45.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>737</start><end>45</end></extent></part><relatedItem type="host"><titleInfo><title>J Clin Epidemiol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>63</number></detail><extent unit="pages"><start>737</start><end>45</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities</title></titleInfo><name type="personal"><namePart type="given">B</namePart><namePart type="family">Aksoy</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A</namePart><namePart type="family">Altaykan‐Hapa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D</namePart><namePart type="family">Egemen</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Aksoy B, Altaykan‐Hapa A, Egemen D et al. The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities. Br J Dermatol2010; 163:719–25.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>163</number></detail><extent unit="pages"><start>719</start><end>25</end></extent></part><relatedItem type="host"><titleInfo><title>Br J Dermatol</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>163</number></detail><extent unit="pages"><start>719</start><end>25</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group</title></titleInfo><name type="personal"><namePart type="given">BE</namePart><namePart type="family">Elewski</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Z</namePart><namePart type="family">Draelos</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B</namePart><namePart type="family">Dréno</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Elewski BE, Draelos Z, Dréno B et al. Rosacea – global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol2011; 25:188–200.</note><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>188</start><end>200</end></extent></part><relatedItem type="host"><titleInfo><title>J Eur Acad Dermatol Venereol</title></titleInfo><part><date>2011</date><detail type="volume"><caption>vol.</caption><number>25</number></detail><extent unit="pages"><start>188</start><end>200</end></extent></part></relatedItem></relatedItem><identifier type="istex">5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4</identifier><identifier type="ark">ark:/67375/WNG-JK3DLJX1-P</identifier><identifier type="DOI">10.1111/j.1365-2133.2012.11148.x</identifier><identifier type="ArticleID">BJD11148</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2012 The Authors. BJD © 2012 British Association of Dermatologists</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-13</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-JK3DLJX1-P/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001B77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:5F7AD8FB52D3FB88C42C8CBDA2D13AF4CECF6CA4
|texte= Lack of ‘appropriately assessed’ patient‐reported outcomes in randomized controlled trials assessing the effectiveness of interventions for rosacea
}}
| This area was generated with Dilib version V0.6.33. |  |